Sensus Healthcare (SRTS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.77, +0.00% vs the prior close of $2.77.
- Volume 12.83K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SRTS ends flat (+0.0%) to $2.77, 6 down days in a row. Closed at $2.77, +0.00% vs the prior close of $2.77. Day range $2.73–$2.82, opened at $2.73.
SRTS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SRTS ends flat (+0.0%) to $2.77, 6 down days in a row
- Closed at $2.77, +0.00% vs the prior close of $2.77. Day range $2.73–$2.82, opened at $2.73.
- Volume was 12.83K shares, 0.4x its 50-day average of 31.80K — lighter than usual.
- Price is -10.4% vs its 50-day average ($3.09) and -23.5% vs its 200-day average ($3.62).
- 52-week range $2.66–$5.49; today's close sits at 4% of that range, 49.5% below the 52-week high.
- That makes 6 straight losses.
Oct 15, 2026 — SRTS slides 3.1% to $2.77, a 3-month low, 5 down days in a row
- Closed at $2.77, -3.15% vs the prior close of $2.86. Day range $2.71–$2.87, opened at $2.85.
- Volume was 26.00K shares, 0.8x its 50-day average of 31.41K.
- Price is -10.5% vs its 50-day average ($3.09) and -23.6% vs its 200-day average ($3.63).
- 52-week range $2.66–$5.49; today's close sits at 4% of that range, 49.5% below the 52-week high.
- That makes 5 straight losses.
Oct 14, 2026 — SRTS dips 1.0% to $2.86, a 1-month low, 4 down days in a row
- Closed at $2.86, -1.04% vs the prior close of $2.89. Day range $2.80–$2.98, opened at $2.89.
- Volume was 10.40K shares, 0.3x its 50-day average of 31.60K — lighter than usual.
- Price is -7.7% vs its 50-day average ($3.10) and -21.3% vs its 200-day average ($3.63).
- 52-week range $2.66–$5.49; today's close sits at 7% of that range, 47.9% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — SRTS dips 1.4% to $2.89, a 1-month low, 3 down days in a row
- Closed at $2.89, -1.37% vs the prior close of $2.93. Day range $2.89–$3.00, opened at $2.91.
- Volume was 18.40K shares, 0.6x its 50-day average of 31.61K — lighter than usual.
- Price is -6.8% vs its 50-day average ($3.10) and -20.5% vs its 200-day average ($3.64).
- 52-week range $2.66–$5.49; today's close sits at 8% of that range, 47.4% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — SRTS dips 0.7% to $2.93
- Closed at $2.93, -0.68% vs the prior close of $2.95. Day range $2.93–$3.01, opened at $2.93.
- Volume was 7.60K shares, 0.2x its 50-day average of 31.59K — lighter than usual.
- Price is -5.5% vs its 50-day average ($3.10) and -19.5% vs its 200-day average ($3.64).
- 52-week range $2.66–$5.49; today's close sits at 10% of that range, 46.6% below the 52-week high.
Oct 9, 2026 — SRTS dips 0.7% to $2.95
- Closed at $2.95, -0.67% vs the prior close of $2.97. Day range $2.93–$3.04, opened at $2.97.
- Volume was 13.20K shares, 0.4x its 50-day average of 31.60K — lighter than usual.
- Price is -4.8% vs its 50-day average ($3.10) and -19.1% vs its 200-day average ($3.65).
- 52-week range $2.66–$5.49; today's close sits at 10% of that range, 46.3% below the 52-week high.
Oct 8, 2026 — SRTS rises 1.0% to $2.97
- Closed at $2.97, +1.02% vs the prior close of $2.94. Day range $2.92–$3.04, opened at $2.92.
- Volume was 19.10K shares, 0.6x its 50-day average of 32.02K — lighter than usual.
- Price is -4.2% vs its 50-day average ($3.10) and -18.6% vs its 200-day average ($3.65).
- 52-week range $2.66–$5.49; today's close sits at 11% of that range, 45.9% below the 52-week high.
Oct 7, 2026 — SRTS dips 1.0% to $2.94
- Closed at $2.94, -1.01% vs the prior close of $2.97. Day range $2.92–$3.05, opened at $2.92.
- Volume was 5.90K shares, 0.2x its 50-day average of 32.06K — lighter than usual.
- Price is -5.0% vs its 50-day average ($3.10) and -19.6% vs its 200-day average ($3.65).
- 52-week range $2.66–$5.49; today's close sits at 10% of that range, 46.4% below the 52-week high.
Oct 6, 2026 — SRTS rises 1.7% to $2.97
- Closed at $2.97, +1.71% vs the prior close of $2.92. Day range $2.90–$3.02, opened at $2.93.
- Volume was 35.30K shares, 1.1x its 50-day average of 31.97K.
- Price is -4.1% vs its 50-day average ($3.10) and -18.8% vs its 200-day average ($3.66).
- 52-week range $2.66–$5.49; today's close sits at 11% of that range, 45.9% below the 52-week high.
Oct 5, 2026 — SRTS dips 2.0% to $2.92
- Closed at $2.92, -2.01% vs the prior close of $2.98. Day range $2.92–$3.04, opened at $3.04.
- Volume was 16.40K shares, 0.5x its 50-day average of 32.02K — lighter than usual.
- Price is -5.7% vs its 50-day average ($3.10) and -20.3% vs its 200-day average ($3.66).
- 52-week range $2.66–$5.49; today's close sits at 9% of that range, 46.8% below the 52-week high.
Oct 2, 2026 — SRTS rises 1.0% to $2.98
- Closed at $2.98, +1.02% vs the prior close of $2.95. Day range $2.92–$3.08, opened at $2.97.
- Volume was 17.20K shares, 0.5x its 50-day average of 32.07K — lighter than usual.
- Price is -3.9% vs its 50-day average ($3.10) and -18.8% vs its 200-day average ($3.67).
- 52-week range $2.66–$5.49; today's close sits at 11% of that range, 45.7% below the 52-week high.
SRTS latest news & SEC filings
Every SEC filing by or about SRTS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sachetta Eric bought 27,304 shares at $3.54 (≈$96.66K) on Aug 31, 2026
- Sachetta Eric bought 27,304 shares at $3.54 (≈$96.66K) on Aug 31, 2026
- Sachetta Eric bought 27,304 shares at $3.54 (≈$96.66K) on Aug 31, 2026
- Sachetta Eric bought 27,304 shares at $3.54 (≈$96.66K) on Aug 31, 2026
- Sachetta Eric bought 37,537 shares at $3.44 (≈$129.13K) on Aug 28, 2026
- Sachetta Eric bought 37,537 shares at $3.44 (≈$129.13K) on Aug 28, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sachetta Eric bought 10,925 shares at $3.18 (≈$34.74K) on Aug 27, 2026
- Sachetta Eric bought 10,925 shares at $3.18 (≈$34.74K) on Aug 27, 2026
- Sachetta Eric bought 10,925 shares at $3.18 (≈$34.74K) on Aug 27, 2026
- Sachetta Eric bought 10,925 shares at $3.18 (≈$34.74K) on Aug 27, 2026
- Sachetta Eric bought 9,708 shares at $3.29 (≈$31.94K) on Aug 26, 2026
- Sachetta Eric bought 9,708 shares at $3.29 (≈$31.94K) on Aug 26, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sachetta Eric bought 34,697 shares at $3.25 (≈$112.77K) on Aug 24, 2026
- Sachetta Eric bought 34,697 shares at $3.25 (≈$112.77K) on Aug 24, 2026
- Sachetta Eric bought 34,697 shares at $3.25 (≈$112.77K) on Aug 24, 2026
- Sachetta Eric bought 34,697 shares at $3.25 (≈$112.77K) on Aug 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sachetta Eric bought 7,000 shares at $3.25 (≈$22.75K) on Aug 21, 2026
- Sachetta Eric bought 7,000 shares at $3.25 (≈$22.75K) on Aug 21, 2026
- Sachetta Eric bought 7,000 shares at $3.25 (≈$22.75K) on Aug 21, 2026
- Sachetta Eric bought 7,000 shares at $3.25 (≈$22.75K) on Aug 21, 2026
- Sachetta Eric bought 24,000 shares at $3.13 (≈$75.12K) on Aug 20, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.29M (prior year $7.32M) (-68.7% vs Jun 30, 2025)
- Net income: -$8.75M (prior year -$1.04M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.53 (prior year -$0.06) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade SRTS
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 12, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.54% (largest 4.0%).
- Liquidity: about 21.84K shares (≈$60.50K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.77 vs a range of $2.66–$5.49 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Eric Sachetta bought 27,304 shares on Aug 31, 2026.
- Latest filings: 10-Q Aug 14, 2026; 8-K Aug 13, 2026; 8-K Jun 5, 2026.
- Share count: 16.46M shares outstanding (Aug 10, 2026), +0.1% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
SRTS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.73 | 2.82 | 2.73 | 2.77 | 12.83K |
| Oct 15, 2026 | 2.85 | 2.87 | 2.71 | 2.77 | 26.00K |
| Oct 14, 2026 | 2.89 | 2.98 | 2.80 | 2.86 | 10.40K |
| Oct 13, 2026 | 2.91 | 3.00 | 2.89 | 2.89 | 18.40K |
| Oct 12, 2026 | 2.93 | 3.01 | 2.93 | 2.93 | 7.60K |
| Oct 9, 2026 | 2.97 | 3.04 | 2.93 | 2.95 | 13.20K |
| Oct 8, 2026 | 2.92 | 3.04 | 2.92 | 2.97 | 19.10K |
| Oct 7, 2026 | 2.92 | 3.05 | 2.92 | 2.94 | 5.90K |
| Oct 6, 2026 | 2.93 | 3.02 | 2.90 | 2.97 | 35.30K |
| Oct 5, 2026 | 3.04 | 3.04 | 2.92 | 2.92 | 16.40K |
| Oct 2, 2026 | 2.97 | 3.08 | 2.92 | 2.98 | 17.20K |
| Oct 1, 2026 | 3.00 | 3.05 | 2.95 | 2.95 | 7.60K |
| Sep 30, 2026 | 3.09 | 3.09 | 2.95 | 2.99 | 19.40K |
| Sep 29, 2026 | 2.97 | 3.08 | 2.97 | 3.07 | 39.70K |
| Sep 28, 2026 | 2.93 | 3.02 | 2.93 | 2.99 | 39.90K |
| Sep 25, 2026 | 2.92 | 2.98 | 2.91 | 2.94 | 23.90K |
| Sep 24, 2026 | 3.01 | 3.09 | 2.91 | 2.91 | 60.50K |
| Sep 23, 2026 | 3.09 | 3.12 | 3.02 | 3.03 | 45.70K |
| Sep 22, 2026 | 3.07 | 3.11 | 3.06 | 3.10 | 7.80K |
| Sep 21, 2026 | 3.04 | 3.10 | 3.03 | 3.07 | 10.00K |
About Sensus Healthcare
Sensus Healthcare (SRTS) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in BOCA RATON, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1494891.
SRTS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Larry Joseph Biscotti | Director | Feb 18, 2026 |
| Eric Sachetta | Director | Aug 31, 2026 |
| Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Aug 24, 2026 |
| Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Dec 16, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Magdalena Martinez | CHIEF OPERATING OFFICER | Apr 22, 2026 |
| Javier Rampolla | CHIEF FINANCIAL OFFICER | Apr 22, 2026 |
| Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Aug 24, 2026 |
| Michael Sardano | PRESIDENT AND GENERAL COUNSEL | Dec 16, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | Eric Sachetta | Buy | 27,304 | $3.54 |
| Aug 31, 2026 | Eric Sachetta | Buy | 27,304 | $3.54 |
| Aug 31, 2026 | Eric Sachetta | Buy | 27,304 | $3.54 |
| Aug 31, 2026 | Eric Sachetta | Buy | 27,304 | $3.54 |
| Aug 28, 2026 | Eric Sachetta | Buy | 37,537 | $3.44 |
| Aug 28, 2026 | Eric Sachetta | Buy | 37,537 | $3.44 |
| Aug 28, 2026 | Eric Sachetta | Buy | 37,537 | $3.44 |
| Aug 28, 2026 | Eric Sachetta | Buy | 37,537 | $3.44 |
| Aug 27, 2026 | Eric Sachetta | Buy | 10,925 | $3.18 |
| Aug 27, 2026 | Eric Sachetta | Buy | 10,925 | $3.18 |
| Aug 27, 2026 | Eric Sachetta | Buy | 10,925 | $3.18 |
| Aug 27, 2026 | Eric Sachetta | Buy | 10,925 | $3.18 |
| Aug 26, 2026 | Eric Sachetta | Buy | 9,708 | $3.29 |
| Aug 26, 2026 | Eric Sachetta | Buy | 9,708 | $3.29 |
| Aug 26, 2026 | Eric Sachetta | Buy | 9,708 | $3.29 |
SRTS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $27.48M | $-7.72M | -0.47 | $528.00K |
| Dec 31, 2024 | $41.81M | $6.65M | 0.41 | $-831.00K |
| Dec 31, 2023 | $24.41M | $485.00K | 0.03 | $-2.15M |
| Dec 31, 2022 | — | $24.24M | 1.46 | $-1.41M |
| Dec 31, 2021 | — | $4.12M | 0.25 | $-286.00K |
Latest balance sheet: total assets $41.26M, total liabilities $4.40M, cash $15.19M (as of Jun 30, 2026).
SRTS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $3.16 |
| May 7, 2026 | 8-K Item 2.02 (results) | $4.11 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $4.65 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $3.52 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $5.35 |
| May 15, 2025 | 8-K Item 2.02 (results) | $4.66 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $8.99 |
| Nov 18, 2024 | 8-K Item 2.02 (results) | $8.41 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $7.29 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SRTS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.